mundipharma corporation limited
mundipharma corporation limited Company Information
Company Number
07688264
Website
www.mundipharma.comRegistered Address
c/o tc bulley davey ltd, 1-4 london road, spalding, lincolnshire, PE11 2TA
Industry
Other personal service activities n.e.c.
Telephone
01223424211
Next Accounts Due
September 2024
Group Structure
View All
mundipharma corporation limited Estimated Valuation
Pomanda estimates the enterprise value of MUNDIPHARMA CORPORATION LIMITED at £16.9k based on a Turnover of £21.1k and 0.8x industry multiple (adjusted for size and gross margin).
mundipharma corporation limited Estimated Valuation
Pomanda estimates the enterprise value of MUNDIPHARMA CORPORATION LIMITED at £0 based on an EBITDA of £0 and a 5.89x industry multiple (adjusted for size and gross margin).
mundipharma corporation limited Estimated Valuation
Pomanda estimates the enterprise value of MUNDIPHARMA CORPORATION LIMITED at £4.9k based on Net Assets of £1.6k and 2.99x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mundipharma Corporation Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Mundipharma Corporation Limited Overview
Mundipharma Corporation Limited is a live company located in spalding, PE11 2TA with a Companies House number of 07688264. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in June 2011, it's largest shareholder is mundipharma international corporation ltd with a 100% stake. Mundipharma Corporation Limited is a established, micro sized company, Pomanda has estimated its turnover at £21.1k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mundipharma Corporation Limited Health Check
Pomanda's financial health check has awarded Mundipharma Corporation Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 5 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
5 Weak
Size
annual sales of £21.1k, make it smaller than the average company (£1.1m)
£21.1k - Mundipharma Corporation Limited
£1.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a faster rate (4.5%)
6% - Mundipharma Corporation Limited
4.5% - Industry AVG
Production
with a gross margin of 41.2%, this company has a comparable cost of product (41.2%)
41.2% - Mundipharma Corporation Limited
41.2% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Mundipharma Corporation Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (15)
- Mundipharma Corporation Limited
15 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Mundipharma Corporation Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £21.1k, this is less efficient (£95.1k)
- Mundipharma Corporation Limited
£95.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Mundipharma Corporation Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Mundipharma Corporation Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Mundipharma Corporation Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (43 weeks)
1 weeks - Mundipharma Corporation Limited
43 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94.5%, this is a higher level of debt than the average (47.2%)
94.5% - Mundipharma Corporation Limited
47.2% - Industry AVG
mundipharma corporation limited Credit Report and Business Information
Mundipharma Corporation Limited Competitor Analysis
Perform a competitor analysis for mundipharma corporation limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
mundipharma corporation limited Ownership
MUNDIPHARMA CORPORATION LIMITED group structure
Mundipharma Corporation Limited has no subsidiary companies.
Ultimate parent company
MUNDIPHARMA INTERNATIONAL CORPORATION LT
#0122162
1 parent
MUNDIPHARMA CORPORATION LIMITED
07688264
mundipharma corporation limited directors
Mundipharma Corporation Limited currently has 3 directors. The longest serving directors include Mr Bryan Lea (Jan 2020) and Mr Bryan Lea (Jan 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Bryan Lea | 62 years | Jan 2020 | - | Director | |
| Mr Bryan Lea | 62 years | Jan 2020 | - | Director | |
| Mr Stephen Jamieson | England | 66 years | Dec 2021 | - | Director |
MUNDIPHARMA CORPORATION LIMITED financials
Mundipharma Corporation Limited's latest turnover from December 2022 is £21.1 thousand and the company has net assets of £1.6 thousand. According to their latest financial statements, we estimate that Mundipharma Corporation Limited has 1 employee and maintains cash reserves of £1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 21,127 | 4,628 | 11,345 | 17,766 | 37,054 | 11,711 | 12,121 | 15,716 | 24,292 | 11,800 | 0 |
| Other Income Or Grants | 0 | 0 | |||||||||
| Cost Of Sales | 0 | 0 | |||||||||
| Gross Profit | 11,800 | 0 | |||||||||
| Admin Expenses | 10,800 | 0 | |||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 2,006 | 2,000 | 2,000 | 2,000 | 2,000 | 1,000 | 0 |
| Interest Payable | 0 | 0 | 0 | 259 | 0 | 0 | 20 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 36 | 0 | 26 | 10 | 0 | 0 | 7 | 0 | 0 |
| Pre-Tax Profit | 0 | 0 | 36 | -259 | 2,032 | 2,010 | 1,980 | 2,000 | 2,007 | 1,000 | 0 |
| Tax | 0 | 0 | 0 | -11,384 | -386 | -387 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 36 | -11,643 | 1,646 | 1,623 | 1,980 | 2,000 | 2,007 | 1,000 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 0 | 0 | 36 | -11,643 | 1,646 | 1,623 | 1,980 | 2,000 | 2,007 | 1,000 | 0 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Number Of Employees | |||||||||||
| EBITDA* | 0 | 0 | 0 | 0 | 2,006 | 2,000 | 2,000 | 2,000 | 2,000 | 1,000 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 26,570 | 5,442 | 8,700 | 17,766 | 38,713 | 11,705 | 12,135 | 20,482 | 4,792 | 12,800 | 0 |
| Misc Debtors | 2,538 | 1,850 | 1,644 | 2,190 | 6,923 | 758 | 593 | 1,102 | 3,921 | 0 | 0 |
| Cash | 1,009 | 5,413 | 4,488 | 5,987 | 11,381 | 12,197 | 14,866 | 1,632 | 8,768 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 30,117 | 12,705 | 14,832 | 25,943 | 57,017 | 24,660 | 27,594 | 23,216 | 17,481 | 12,800 | 0 |
| total assets | 30,117 | 12,705 | 14,832 | 25,943 | 57,017 | 24,660 | 27,594 | 23,216 | 17,481 | 12,800 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 144 | 146 | 33,445 | 0 | 961 | 3,432 | 0 | 2,000 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 5,000 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 28,468 | 11,056 | 13,039 | 26,184 | 12,316 | 15,050 | 13,646 | 13,777 | 13,474 | 8,800 | 0 |
| total current liabilities | 28,468 | 11,056 | 13,183 | 26,330 | 45,761 | 15,050 | 19,607 | 17,209 | 13,474 | 10,800 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 28,468 | 11,056 | 13,183 | 26,330 | 45,761 | 15,050 | 19,607 | 17,209 | 13,474 | 10,800 | 0 |
| net assets | 1,649 | 1,649 | 1,649 | -387 | 11,256 | 9,610 | 7,987 | 6,007 | 4,007 | 2,000 | 0 |
| total shareholders funds | 1,649 | 1,649 | 1,649 | -387 | 11,256 | 9,610 | 7,987 | 6,007 | 4,007 | 2,000 | 0 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 2,006 | 2,000 | 2,000 | 2,000 | 2,000 | 1,000 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | -11,384 | -386 | -387 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 21,816 | -3,052 | -9,612 | -25,680 | 33,173 | -265 | -8,856 | 12,871 | -4,087 | 12,800 | 0 |
| Creditors | 0 | -144 | -2 | -33,299 | 33,445 | -961 | -2,471 | 3,432 | -2,000 | 2,000 | 0 |
| Accruals and Deferred Income | 17,412 | -1,983 | -13,145 | 13,868 | -2,734 | 1,404 | -131 | 303 | 4,674 | 8,800 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -4,404 | 925 | -3,535 | -5,135 | -842 | 2,321 | 8,254 | -7,136 | 8,761 | -1,000 | 0 |
| Investing Activities | |||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | -5,000 | 5,000 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | 0 | 0 | 36 | -259 | 26 | 10 | -20 | 0 | 7 | 0 | 0 |
| cash flow from financing | 0 | 0 | 2,036 | -259 | 26 | -4,990 | 4,980 | 0 | 7 | 1,000 | 0 |
| cash and cash equivalents | |||||||||||
| cash | -4,404 | 925 | -1,499 | -5,394 | -816 | -2,669 | 13,234 | -7,136 | 8,768 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -4,404 | 925 | -1,499 | -5,394 | -816 | -2,669 | 13,234 | -7,136 | 8,768 | 0 | 0 |
P&L
December 2022turnover
21.1k
+357%
operating profit
0
0%
gross margin
41.2%
+1.82%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
1.6k
0%
total assets
30.1k
+1.37%
cash
1k
-0.81%
net assets
Total assets minus all liabilities
mundipharma corporation limited company details
company number
07688264
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
June 2011
age
13
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
c/o tc bulley davey ltd, 1-4 london road, spalding, lincolnshire, PE11 2TA
last accounts submitted
December 2022
mundipharma corporation limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mundipharma corporation limited.
mundipharma corporation limited Companies House Filings - See Documents
| date | description | view/download |
|---|
